Efficacy Study of IL-21 to Treat Metastatic Melanoma
Clinical trial NCT00336986 · COMPLETED
Trial details
- NCT number
- NCT00336986
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2007-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.